JPS5943471B2 - 1-(2-tetrahydrofuryl)-5-fluorouracil - Google Patents

1-(2-tetrahydrofuryl)-5-fluorouracil

Info

Publication number
JPS5943471B2
JPS5943471B2 JP15340375A JP15340375A JPS5943471B2 JP S5943471 B2 JPS5943471 B2 JP S5943471B2 JP 15340375 A JP15340375 A JP 15340375A JP 15340375 A JP15340375 A JP 15340375A JP S5943471 B2 JPS5943471 B2 JP S5943471B2
Authority
JP
Japan
Prior art keywords
fluorouracil
reaction
tetrahydrofuryl
added
dihydrofuran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP15340375A
Other languages
Japanese (ja)
Other versions
JPS52125177A (en
Inventor
辰郎 横山
温 小島
嘉嗣 神野
祥雅 池
誠 尾館
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP15340375A priority Critical patent/JPS5943471B2/en
Priority to DK539376AA priority patent/DK142415B/en
Priority to NO764136A priority patent/NO145575C/en
Priority to SE7613751A priority patent/SE7613751L/en
Priority to GB50989/76A priority patent/GB1522860A/en
Priority to CA267,561A priority patent/CA1114376A/en
Priority to US05/749,433 priority patent/US4256885A/en
Priority to DE2656604A priority patent/DE2656604C3/en
Priority to FI763665A priority patent/FI63758C/en
Priority to PH19272A priority patent/PH15812A/en
Priority to NL7614220A priority patent/NL7614220A/en
Priority to PT66013A priority patent/PT66013B/en
Priority to AT961176A priority patent/AT347477B/en
Priority to FR7638941A priority patent/FR2336401A1/en
Priority to CH1631676A priority patent/CH623583A5/de
Publication of JPS52125177A publication Critical patent/JPS52125177A/en
Publication of JPS5943471B2 publication Critical patent/JPS5943471B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、1−(2−テトラヒドロフリル)一5−フル
オロウラシルの製造法に関するもので、詳しくは、5−
フルオロウラシルと2、3−ジヒ 、’ドロフランとを
アミン塩の存在下で反応させて1−(2−テトラヒドロ
フリル)−5−フルオロウラシルを製造する方法に関す
るものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing 1-(2-tetrahydrofuryl)-5-fluorouracil.
The present invention relates to a method for producing 1-(2-tetrahydrofuryl)-5-fluorouracil by reacting fluorouracil and 2,3-dihydrofuran in the presence of an amine salt.

1−(2−テトラヒドロフリル)−5−フルオロウラシ
ルは、抗腫瘍剤、抗ビールス剤などとして、よ、’く知
られた化合物であり、その製造法としても、いくつかの
方法が知られている。
1-(2-tetrahydrofuryl)-5-fluorouracil is a well-known compound as an antitumor agent, antiviral agent, etc., and several methods are known for its production. .

例えば、英国特許第1168391号明細書には、5−
フルオロウラシルの水銀塩に2−クロロテトラヒドロフ
ランを反応させる方法が記載されており、また、特公昭
49−10510号公報には、2、4−ビス(トリメチ
ルシリル)−5−フルオロウラシルに2−クロロテトラ
ヒドロフランを反応させる方法が記載されている。さら
にペルキー国特許第807556号明細書には、2、4
−ビス(トリメチルシリル)−5−フルオロウラシルに
2−アシロキシテトラヒドロフランまたは2−アルコキ
シテトラヒドロフランを反応させる方法も記載されてい
る。しかしながら、最初に掲げた方法は、反応に使用す
る2−クロロテトラヒドロフランがきわめて不安定な化
合物であるため、−60〜−10℃くらいの低温度で反
応を行なわなければならないばかりでなく、5−フルオ
ロウラシルの水銀塩を用いるため公害問題を惹起するお
それがある。第二の方法も、2−クロロテトラヒドロフ
ランを使用するための工業的不利益はまぬがれないばか
りでなく、5−フルオロウラシルを、一旦、反応容易な
2、4−ビス(トリメチルシリル)一5−フルオロウラ
シルに変換しなければならず、工程の複雑化、コストの
増大は避けられない。さらに第三の方法も2、4−ビス
(トリメチルシリル)−5−フルオロウラシルを用いる
点では、第二の方法と同様であるぱかりでなく、2−ア
シロキシテトラヒドロフランおよび2−アルコキシテト
ラヒドロフランは、通常2−クロロテトラヒドロフラン
から調製される化合物であるから、決して工業的に有利
な方法とは云えない。本発明者は、これら公知方法の欠
点を改善し、工業的に有利に1−(2−テトラヒドロフ
リル)−5−フルオロウラシルを製造する方法を案出す
る目的で研究を重ねた結果、反応促進剤としてアミン塩
類を用いることによつて、5−フルオロウラシルが2、
3−ジヒドロフランと容易に反応し、1−(2−−テト
ラヒドロフリル)−5−フルオロウラシルを生成するこ
とを見出して本発明を完成するに至つたものである。
For example, in British Patent No. 1168391, 5-
A method is described in which mercury salt of fluorouracil is reacted with 2-chlorotetrahydrofuran, and Japanese Patent Publication No. 49-10510 describes a method in which 2,4-bis(trimethylsilyl)-5-fluorouracil is reacted with 2-chlorotetrahydrofuran. It describes how to do this. Furthermore, in Pelky Patent No. 807556, 2, 4
A method for reacting -bis(trimethylsilyl)-5-fluorouracil with 2-acyloxytetrahydrofuran or 2-alkoxytetrahydrofuran is also described. However, in the first method, the 2-chlorotetrahydrofuran used in the reaction is an extremely unstable compound, so not only does the reaction have to be carried out at a low temperature of -60 to -10°C, but also 5-chlorotetrahydrofuran is an extremely unstable compound. Since mercury salt of fluorouracil is used, there is a risk of causing pollution problems. In the second method, not only is there an unavoidable industrial disadvantage due to the use of 2-chlorotetrahydrofuran, but also 5-fluorouracil is first converted into 2,4-bis(trimethylsilyl)-5-fluorouracil, which is easy to react. However, the complexity of the process and the increase in cost are unavoidable. Furthermore, the third method is not only similar to the second method in that it uses 2,4-bis(trimethylsilyl)-5-fluorouracil, but also 2-acyloxytetrahydrofuran and 2-alkoxytetrahydrofuran, which are usually 2- Since the compound is prepared from chlorotetrahydrofuran, it cannot be said to be an industrially advantageous method. As a result of repeated research aimed at improving the drawbacks of these known methods and devising an industrially advantageous method for producing 1-(2-tetrahydrofuryl)-5-fluorouracil, the present inventor discovered that the reaction accelerator By using amine salts as 5-fluorouracil, 2,
The present invention was completed by discovering that it easily reacts with 3-dihydrofuran to produce 1-(2-tetrahydrofuryl)-5-fluorouracil.

本発明について、さらに詳細な説明を加えれば、本発明
で使用する反応促進剤としては、有機アミンの無機酸塩
または有機酸遍、例えば、メチルアミン、ジメチルアミ
ン、トリエチルアミン、ビリジン、ビコリン、ルチジン
、キノリン、ジメチルアニリンなどの塩酸塩、臭素酸塩
、沃素塩、硫酸塩、ベンゼンスルホン酸塩、p−トルエ
ンスルホン酸塩、酢酸塩、トリフルオロ酢酸塩などが適
当であり、またN−メチルビリジニウム塩、テトラメチ
ルアンモニウム塩などの四級アンモニウム塩も使用でき
る。
To give a more detailed explanation of the present invention, the reaction accelerator used in the present invention includes inorganic acid salts of organic amines or organic acid salts, such as methylamine, dimethylamine, triethylamine, viridine, vicoline, lutidine, Hydrochlorides, bromates, iodine, sulfates, benzenesulfonates, p-toluenesulfonates, acetates, trifluoroacetates, etc. of quinoline, dimethylaniline, etc. are suitable; Quaternary ammonium salts such as nium salts and tetramethylammonium salts can also be used.

アミン塩の使用量は、5−フルオロウラシルに対して、
0.01モル比以上でよい。5−フルオロウラシルと2
3−ジヒドロフラランとの反応は、溶媒を使用せずに行
なつてもよいが、通常は溶媒中、上記のようなアミン塩
の存在下で行なうのが適当である。
The amount of amine salt used is based on 5-fluorouracil.
The molar ratio may be 0.01 or more. 5-Fluorouracil and 2
Although the reaction with 3-dihydrofurarane may be carried out without using a solvent, it is usually appropriate to carry out the reaction in a solvent in the presence of the above-mentioned amine salt.

反応溶媒としては、例えば、ジメチルスルホキシド、ジ
メチルアセトアミド、ヘキサメチルホスホルアミドピリ
ジン、ピリコン、キノリン、トリエチルアミンなどが適
当である。一般に5−フルオロウラシルを溶解する溶媒
が適当であるが、5−フルオロウラシルをあまり溶解し
ない溶媒でも、5−フルオロウラシルを懸濁状態にして
反応を行なえば使用できる。反応温度は通常、0〜20
0℃でよい。反応終了後、反応液を常法に従つて処理し
、1−(2−テトラヒドロフリル)−5−フルオロウラ
シルを単離する。
Suitable reaction solvents include, for example, dimethyl sulfoxide, dimethylacetamide, hexamethylphosphoramide pyridine, pyricone, quinoline, and triethylamine. Generally, a solvent that dissolves 5-fluorouracil is suitable, but a solvent that does not dissolve 5-fluorouracil very well can also be used if the reaction is carried out with 5-fluorouracil in a suspended state. The reaction temperature is usually 0 to 20
0°C is sufficient. After the reaction is completed, the reaction solution is treated in a conventional manner to isolate 1-(2-tetrahydrofuryl)-5-fluorouracil.

本発明によれば、1−(2−テトラヒドロフリル)−5
−フルオロウラシルを容易に、かつ、収率よく製造する
ことができる。
According to the invention, 1-(2-tetrahydrofuryl)-5
- Fluorouracil can be easily produced with good yield.

以下実施例により、本発明を具体的に説明する。The present invention will be specifically explained below with reference to Examples.

実施例 15−フルオロウラシル2.59およびp−ト
ルエンスルホン酸0.4f1をビリジン50m1に溶か
し2,3−ジヒドロフラン1.5m1を加えて油浴上、
120℃で6時間反応させた。
Example 1 2.59 ml of 5-fluorouracil and 0.4 f1 of p-toluenesulfonic acid were dissolved in 50 ml of pyridine, and 1.5 ml of 2,3-dihydrofuran was added, and the mixture was heated on an oil bath.
The reaction was carried out at 120°C for 6 hours.

さらに2,3−ジヒドロフラン3m1を4回に分けて加
え、15時間反応させた。反応終了後、反応液からピリ
ジンを留去し、次いで残分にクロロホルム100m1を
加えて溶解させたのちP過して不溶物を分解した。p液
を水洗、乾燥したのちクロロホルムを留去して濃縮し、
析出した結晶をP取した。この結晶を少量のエーテルで
洗浄し乾燥して、1−(2−テトラヒドロフリル)−5
−フルオロウラシル2.09を得た。この結晶の融点は
、167〜168℃であり、その赤外線吸収スペクトル
は、標品のそれとよく一致した。先に分離したクロロホ
ルム不溶物を水洗して、原料の5−フルオロウラシル0
.679を回収した。
Further, 3 ml of 2,3-dihydrofuran was added in four portions, and the reaction was allowed to proceed for 15 hours. After the reaction was completed, pyridine was distilled off from the reaction solution, and 100 ml of chloroform was added to the residue to dissolve it, followed by filtration with P to decompose insoluble matter. After washing the p solution with water and drying it, chloroform was distilled off and concentrated.
The precipitated crystals were collected by P. The crystals were washed with a small amount of ether and dried to produce 1-(2-tetrahydrofuryl)-5.
-Fluorouracil 2.09 was obtained. The melting point of this crystal was 167-168°C, and its infrared absorption spectrum matched well with that of the standard product. The previously separated chloroform insoluble matter was washed with water to remove the raw material 5-fluorouracil 0.
.. 679 were recovered.

消費した5−フルオロウラシルに対する目的化合物の収
率は71%であつた。実施例 2 5−フルオロウラシル2.59およびピリジン塩酸塩2
.49をピリジン50m1に溶かし、これに2,3−ジ
ヒドロフラン4.5m1を4回に分けて20時間かかつ
て加え油浴上、120℃で反応を行なつた。
The yield of the target compound based on the consumed 5-fluorouracil was 71%. Example 2 5-fluorouracil 2.59 and pyridine hydrochloride 2
.. 49 was dissolved in 50 ml of pyridine, and 4.5 ml of 2,3-dihydrofuran was added in 4 portions for 20 hours, and the reaction was carried out on an oil bath at 120°C.

反応液の少量を採取して薄層クロマトグラフイにより反
応の進行状況を調べたところ、目的化合物90%、未反
応5−フルオロウラシル5%、副生物50!)であるこ
とがわかつた。反応液を実施例1と同様に処理して、1
−(2−テトラヒドロフリル)−5−フルオロウラシル
2.69を得た。最初に使用した5−フルオロウラシル
に対する目的化合物の収率は70%であつた。実施例
3 5−フルオロウラシル1,39およびテトラメチルアン
モニウムクロリド0.69をジメチルホルムアミド20
m1に溶かし、次いで2,3−ジヒドロフラン2.25
m1を加えて、オートクレープ中、150℃で9時間反
応を行なつた。
When a small amount of the reaction solution was collected and the progress of the reaction was examined by thin layer chromatography, it was found that the target compound was 90%, unreacted 5-fluorouracil was 5%, and by-products were 50%! ). The reaction solution was treated in the same manner as in Example 1 to obtain 1
-(2-tetrahydrofuryl)-5-fluorouracil 2.69 was obtained. The yield of the target compound was 70% based on the initially used 5-fluorouracil. Example
3 5-fluorouracil 1,39 and tetramethylammonium chloride 0.69 in dimethylformamide 20
m1, then 2,3-dihydrofuran 2.25
m1 was added thereto, and the reaction was carried out at 150° C. for 9 hours in an autoclave.

反応後、反応液からジメチルホルムアミドを留去し、残
分にクロロホルムと少量の水を加えて攪拌し、P過して
不溶物を分離した。沢液のクロロホルム層を乾燥したの
ち濃縮し、析出した結晶をP取した。この結晶をエーテ
ルで洗浄し、乾燥して1−(2−テトラヒドロフリル)
−5−フルオロウラシル0.859を得た。融点165
〜168℃。先に分離したクロロホルム不溶物から、原
料の5−フルオロウラシル0.59を回収した。消費し
た5−フルオロウラシルに対する目的化合物の収率は、
69%であつた。実施例 4 5−フルオロウラシル1.39およびN,N−ジメチル
アニリン酢酸塩1.89をジメチルホルムアミド15m
1に溶かし、次いで2,3−ジヒドロフラン1.5m1
を加えて140℃で20時間反応させた。
After the reaction, dimethylformamide was distilled off from the reaction solution, chloroform and a small amount of water were added to the residue, stirred, and filtered through P to separate insoluble materials. The chloroform layer of the solution was dried and concentrated, and the precipitated crystals were collected. The crystals were washed with ether and dried to produce 1-(2-tetrahydrofuryl).
-5-fluorouracil 0.859 was obtained. Melting point 165
~168℃. 0.59 of 5-fluorouracil, a raw material, was recovered from the previously separated chloroform-insoluble matter. The yield of the target compound based on consumed 5-fluorouracil is:
It was 69%. Example 4 1.39 of 5-fluorouracil and 1.89 of N,N-dimethylaniline acetate were dissolved in 15 m of dimethylformamide.
1, then 1.5 ml of 2,3-dihydrofuran
was added and reacted at 140°C for 20 hours.

反応後、反応液よりジメチルホルムアミドを留去したの
ち、残分に酢酸1(:Fk)を含むエタノール50m1
を加えて30分間、加温した。次いで、エタノールを留
去し、残分にクロロホルムと水とを加えて攪拌した。分
液してクロロホルム層を分取し乾燥したのち、クロロホ
ルムを留去して、1(2−テトラヒドロフリル)−5−
フルオロウラシル1.59を得た。最初に使用した5−
フルオロウラシルに対する目的化合物の収率は75%で
あつた。実施例 5 5−フルオロウラシル1.39およびトリエチルアミン
塩酸塩0.419をジメチルホルムアミド15m1に溶
かし、次いで2,3−ジヒドロフラン3dを加えてオー
トクレープ中、150℃で16時間反応させた。
After the reaction, dimethylformamide was distilled off from the reaction solution, and 50 ml of ethanol containing 1 acetic acid (:Fk) was added to the residue.
was added and heated for 30 minutes. Next, ethanol was distilled off, and chloroform and water were added to the residue and stirred. After separating the chloroform layer and drying it, chloroform was distilled off and 1(2-tetrahydrofuryl)-5-
1.59 fluorouracil was obtained. First used 5-
The yield of the target compound based on fluorouracil was 75%. Example 5 1.39% of 5-fluorouracil and 0.419% of triethylamine hydrochloride were dissolved in 15ml of dimethylformamide, and then 3d of 2,3-dihydrofuran was added and reacted in an autoclave at 150°C for 16 hours.

Claims (1)

【特許請求の範囲】[Claims] 1 5−フルオロウラシルと2,3−ジヒドロフランと
をアミン塩の存在下で反応させることを特徴とする1−
(2−テトラヒドロフリル)−5−フルオロウラシルの
製造法。
1-1, characterized in that 5-fluorouracil and 2,3-dihydrofuran are reacted in the presence of an amine salt.
A method for producing (2-tetrahydrofuryl)-5-fluorouracil.
JP15340375A 1975-12-24 1975-12-24 1-(2-tetrahydrofuryl)-5-fluorouracil Expired JPS5943471B2 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP15340375A JPS5943471B2 (en) 1975-12-24 1975-12-24 1-(2-tetrahydrofuryl)-5-fluorouracil
DK539376AA DK142415B (en) 1975-12-24 1976-11-30 Process for the preparation of 1- (2-tetrahydrofuryl) -5-fluorouracil.
NO764136A NO145575C (en) 1975-12-24 1976-12-03 PROCEDURE FOR PREPARING 1- (2'-TETRAHYDROFURYL) -5-FLUORURACIL
SE7613751A SE7613751L (en) 1975-12-24 1976-12-07 PROCEDURE FOR THE PREPARATION OF 1- (2-TETRAHYDROFURYL) -5-FLUOROURACIL
GB50989/76A GB1522860A (en) 1975-12-24 1976-12-07 Process for the preparation of 1 - (2-tetrahydrofuryl) - 5 - fluorouracil
CA267,561A CA1114376A (en) 1975-12-24 1976-12-09 Process for the preparation of 1-(2-tetrahydrofuryl)- 5-fluorouracil
US05/749,433 US4256885A (en) 1975-12-24 1976-12-10 Process for the preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil
DE2656604A DE2656604C3 (en) 1975-12-24 1976-12-14 Process for the preparation of 1 - (2-tetrahydrofuryl) -5-fluoro-uracil
FI763665A FI63758C (en) 1975-12-24 1976-12-21 REFRIGERATION FOR FRAMSTAELLNING AV 1- (2-TETRAHYDROFURYL) -5-FLUORURACIL
PH19272A PH15812A (en) 1975-12-24 1976-12-21 Process for the preparation of 1-(2-tetrahydrofuryl)5-fluorouracil
NL7614220A NL7614220A (en) 1975-12-24 1976-12-21 PROCESS FOR THE PREPARATION OF 1- (2-TETRAHYDRO-FURYL) -5-FLUORURACIL.
PT66013A PT66013B (en) 1975-12-24 1976-12-23 Process for the preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil
AT961176A AT347477B (en) 1975-12-24 1976-12-23 METHOD FOR PRODUCING 1- (2- TETRAHYDROFURYL) -5-FLUOROURACIL
FR7638941A FR2336401A1 (en) 1975-12-24 1976-12-23 PROCESS FOR THE PREPARATION OF 1- (2-TETRAHYDROFURYL) -5-FLUOROURACIL
CH1631676A CH623583A5 (en) 1975-12-24 1976-12-24

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15340375A JPS5943471B2 (en) 1975-12-24 1975-12-24 1-(2-tetrahydrofuryl)-5-fluorouracil

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP15188776A Division JPS5285180A (en) 1976-12-20 1976-12-20 Preparation of 1,3-bis(2-tetrahydrofuryl)-5-fluorouracil

Publications (2)

Publication Number Publication Date
JPS52125177A JPS52125177A (en) 1977-10-20
JPS5943471B2 true JPS5943471B2 (en) 1984-10-22

Family

ID=15561716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15340375A Expired JPS5943471B2 (en) 1975-12-24 1975-12-24 1-(2-tetrahydrofuryl)-5-fluorouracil

Country Status (1)

Country Link
JP (1) JPS5943471B2 (en)

Also Published As

Publication number Publication date
JPS52125177A (en) 1977-10-20

Similar Documents

Publication Publication Date Title
JPH0130823B2 (en)
JPS5943471B2 (en) 1-(2-tetrahydrofuryl)-5-fluorouracil
JPS5949221B2 (en) Method for producing 3-acylamino-4-homoisotwistane
JPH0269476A (en) Production of pyrimidine derivative
EP0070467B1 (en) Process for synthesising n-isopropyl-n'-o-carbomethoxyphenylsulphamide
JP4159022B2 (en) Preparation of diazonaphthoquinonesulfonyl chloride using diphosgene and triphosgene.
JPS5916878A (en) Production of 2,4-dihydroxy-3-acetylquinoline
JPH08208591A (en) 2-aminobenzenesulfonic acid derivative and 2-aminobenzenesulfonyl chloride,derivative their production,and their use as synthetic intermediates
US2482521A (en) Halogenated phenacylpyridines
KR790000869B1 (en) Process for producing 1-(2-tetra hydropril)-5-feluorouracil
JP2563864B2 (en) Method for producing 2- (3,4-dimethoxystyryl) -3,1-benzoxazin-4-one
JPS6316374B2 (en)
JPS606944B2 (en) Method for producing new uracil derivatives
JPS636557B2 (en)
JPS582944B2 (en) Method for producing 4(5)-siaimidazole-5(4)-carboxamide
JPS6159309B2 (en)
JPH1029981A (en) Production of hexahydropyridazine compound
JPS5916879A (en) Production of n-substituted imidazole
JPH0322381B2 (en)
JPS5833861B2 (en) Method for producing 3-acylamino-4-homoisotwistane
Paegle et al. Synthesis and reactions of β-(5-halo-3-uracyl) propionic acids
JPH07103115B2 (en) Method for crystallizing 2- (10,11-dihydro-10-oxodibenzo [b, f] thiepin-2-yl) propionic acid
JPS62178570A (en) Production of 1,4-dihydropyridine derivative
JPS62132870A (en) Purification of n-(2-hydroxyethyl)-2-methyl-3-carboxylic acid amido-quinoxaline-1,4-di-n-oxide
JPH0657688B2 (en) Method for producing fluorodinitrobenzene derivative